Grants for Special district governments - Food and Nutrition

This funding opportunity provides financial support to educational institutions, nonprofits, and government entities to enhance surveillance of antibiotic resistance in bacteria found in retail food, particularly raw meats and seafood.

This grant provides funding to support outstanding postdoctoral researchers in transitioning to independent faculty roles while conducting clinical trials and developing their own research programs.

This funding opportunity supports full-time research software engineers at academic institutions who are working on NIH-funded projects, enabling them to develop and maintain essential software tools for biomedical and health research.

This funding opportunity supports researchers and institutions in developing innovative, non-addictive pain treatments through early-stage drug discovery and assay development, with a focus on alternatives to opioid therapies.

This funding opportunity supports research on HIV/AIDS-related health issues, particularly focusing on complications affecting organs like the liver and kidneys, and aims to improve understanding of how HIV interacts with various bodily systems and social factors.

This grant provides funding to Virginia's local governments for infrastructure projects that enhance local food production and sustainable agriculture, prioritizing initiatives like processing facilities and farmers markets, especially in economically distressed areas.

This funding opportunity provides $2 million to a variety of organizations for research projects focused on improving pain management, anesthesia safety, and addiction treatment strategies.

This program provides funding to early-career researchers who have received specific NIDDK K awards, enabling them to conduct small-scale research projects that will help them transition to independent investigator roles.

The Ellensburg Community Grant Program offers a water quality focused grant to encourage community-based projects that improve or protect the quality of surface waters. Donor Name: City of Ellensburg State: Washington City: Ellensburg Type of Grant: Grant Deadline:  08/30/2024 Size of the Grant: $1000 to $10,000 Grant Duration: Grant Duration Not Mentioned Details: Funded by the Stormwater Utility, the water quality grant provides funding for community groups to provide outreach, education, assessments, planning, implementation, prevention and control focused on city’s surface water. Water quality is commonly defined by its physical, chemical, biological, and aesthetic (appearance and smell) characteristics. A healthy environment is one in which the water quality supports a rich and varied community of organisms and protects public health. Grant funds are invested in projects that include one or more of the following priorities: Required: Demonstrate improvements in quality of surface waters. Educate a large and/or varied segments of Ellensburg’s population on what water quality is, and what actions they can take to improve or protect it. Educate best practices to reduce/eliminate adverse impacts to water quality. Funding Information A total of $10,000 is available for this grant cycle. Eligibility Criteria Eligible volunteer groups such as youth, seniors, non-profit organizations, educational organizations may apply for funding. Business and governmental partners are encouraged but may not be the applicant. Projects must benefit stormwater quality within the City limits, (i.e., public outreach and education, yard care, litter pick up, etc.). Projects must be within the city limits; if the project is on publicly owned property, an agreement will need to be signed between both parties addressing use of minors as volunteers, hold harmless, etc. Grant funds may not be used for projects that involve or promote the use of alcohol. For more information, visit City of Ellensburg.

This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), and solicits Research Project (R01) grant applications from institutions or organizations that propose to develop or support the development of designated new animal drugs intended for minor uses in major species or for use in minor species (MUMS). The FDA is authorized to provide grants to assist in defraying the costs of qualified safety and effectiveness testing that could be used to satisfy the requirements for FDA approval of MUMS-designated drugs.Only entities developing drugs for veterinary use or parties working as research partners with such entities are eligible for grants.The organization (or applicant) seeking approval of the new animal drug under investigation must have opened an Investigational New Animal Drug (INAD) file with FDA/CVM and must hold a minor use or minor species "designation" granted by FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) for that drug for a specified intended use, in accordance with the provisions of section 573 of the Food, Drug and Cosmetic Act (21 U.S.C. 360ccc-2) and 21 CFR part 516.FDA/CVM's Office of New Animal Drug Evaluation (ONADE) must have reviewed and concurred with the proposed study protocol before an applicant can submit a grant application.

This funding opportunity is designed to establish a center that will coordinate and advance research on whole person health by integrating diverse biomedical knowledge and fostering collaboration among researchers.

The "Type 1 Diabetes TrialNet Clinical Network Hub" grant aims to support the coordination unit for clinical trials focused on preventing and intervening early in type 1 diabetes, by improving communication, outreach, and developing new strategies for better screening, recruitment, and retention of participants.

This grant provides funding for interdisciplinary research teams to explore the neural and behavioral aspects of benign urological conditions, aiming to improve understanding and treatment of these diseases.

The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA.

The purpose of this program is to support projects that will treat invasive plant infestations that threaten forested, woodland, or rangeland areas. The theme for the FY 2024 funding cycle is grasses and grasslands. Projects may occur on state, federal, tribal, and private lands in Arizona.  This program focuses on the prevention, control/removal, and eradication of invasive plants and aims to achieve the following objectives: Target and treat invasive plants that are capable of transforming native plant communities in forests, woodlands, deserts, or rangeland Assist in preventing fire and flooding, conserving water, and restoring habitat to wildlife Use an integrated weed management (IWM) approach when treating areas infested with invasive plants through the utilization of available tools, including manual, cultural, mechanical, chemical, and biological control methods Examples of eligible projects include: Control/removal or eradication of invasive plants Replacement of invasive plants with native plants through reseeding and planting Removal of woody invasive plant slash by mulching or grinding Examples of eligible costs include those in the following categories: Administrative labor Project labor Fringe benefits Travel Equipment Supplies Contractual Financial Notes: Match Notes: Applicants must provide at least 10 percent of the total project costs via cash and/or in-kind contributions. Priority may be given to projects that provide a higher-than-required match amount, not to exceed 50 percent. Specifically allowable matching contributions include: Cash paid by award recipients In-kind expenses, including necessary costs incurred by award recipients or other organizations to support the project Volunteer hours at a reasonable rate Donated labor and/or equipment necessary to complete the specific project Physical work performed by individual landowners on their own property Funding Notes: A total of $970,000 is available to support awards ranging from $50,000 to $200,000 through this program. Funds will be provided on a reimbursement basis. Awards are expected to be issued in fall and winter 2024/2025. Specifically, award announcements are expected around October 2024. Proposed projects should be ready for implementation upon receipt of award and should be fully achievable within the prescribed award period. Projects must be considered shovel-ready. Funds may not be used for: Research and development projects Website, geographic information system (GIS), and database projects Projects that only include assessment activity and no related treatment of invasive plants Projects that include purchase of capital equipment valued at over $5,000 per item Expenses incurred prior to execution of a formal written agreement between the funding agency and the award recipient Reimbursement of physical work performed by individual landowners on their own property Food or beverage purchases

The objective of this Notice of Funding Opportunity (NOFO) is to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical Research Network (RDCRN). The RDCRCs are intended to advance and improve diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational and clinical research. Special emphasis will be placed on the early and timely identification of individuals with rare diseases and clinical trial readiness.

This funding opportunity provides financial support to researchers with active NIH grants to address unexpected costs and enhance their projects without changing the original research scope.

This funding opportunity supports research that explores the effects of aging on individuals living with HIV, focusing on improving health outcomes and management strategies for this population.

This funding opportunity supports U.S.-based organizations in evaluating the impact of upcoming public policies and programs that aim to improve health behaviors and reduce chronic disease risk factors through behavioral changes.

This funding opportunity supports U.S.-based researchers and organizations in developing non-addictive pain relief therapies to combat the opioid crisis, with a focus on advancing preclinical candidates toward clinical trials.